Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Farrar

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
The World Allergy Organization Journal|November 16, 2013
Section 4. What the guidelines have missed: a general discussion of the faculty: highlights of the asthma summit 2009: beyond the guidelinesJudith R Farrar, Michael A Kaliner
The World Allergy Organization Journal|November 16, 2013
Summary and recommendations: highlights of the asthma summit 2009: beyond the guidelinesMichael A Kaliner, Judith R Farrar
Bulletin of the New York Academy of Medicine|December 1, 1976
The neuropathic foot of the diabeticH I Lippmann, A Perotto, R Farrar
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|January 27, 2007
Damage prognosis: the future of structural health monitoringCharles R Farrar, Nick A J Lieven
American Journal of Botany|June 2, 2011
The sporophyte-less filmy fern of eastern North America Trichomanes intricatum (Hymenophyllaceae) has the chloroplast genome of an Asian speciesAtsushi Ebihara, Donald R Farrar, Motomi Ito
Optometry (St. Louis, Mo.)|August 7, 2001
A comparison of the visual symptoms between ADD/ADHD and normal childrenR Farrar, M Call, W C Maples
American Journal of Botany|April 9, 2016
Cryptic speciation in allotetraploids: Lessons from the Botrychium matricariifolium complexEvelyn W Williams, Donald R Farrar, Don Henson
Allergy and Asthma Proceedings|April 22, 2010
Comprehensive review of olopatadine: the molecule and its clinical entitiesMichael A Kaliner, John Oppenheimer, Judith R Farrar
Allergy and Asthma Proceedings|April 25, 2012
Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data reviewWilliam Storms, Matthew S Bowdish, Judith R Farrar
Clinical Therapeutics|September 1, 1996
A retrospective assessment of cost avoidance associated with the use of nedocromil sodium metered-dose inhaler in the treatment of patients with asthmaP Thomas, R N Ross, J R Farrar
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
The World Allergy Organization Journal|November 16, 2013
Section 4. What the guidelines have missed: a general discussion of the faculty: highlights of the asthma summit 2009: beyond the guidelinesJudith R Farrar, Michael A Kaliner
The World Allergy Organization Journal|November 16, 2013
Summary and recommendations: highlights of the asthma summit 2009: beyond the guidelinesMichael A Kaliner, Judith R Farrar
Bulletin of the New York Academy of Medicine|December 1, 1976
The neuropathic foot of the diabeticH I Lippmann, A Perotto, R Farrar
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|January 27, 2007
Damage prognosis: the future of structural health monitoringCharles R Farrar, Nick A J Lieven
American Journal of Botany|June 2, 2011
The sporophyte-less filmy fern of eastern North America Trichomanes intricatum (Hymenophyllaceae) has the chloroplast genome of an Asian speciesAtsushi Ebihara, Donald R Farrar, Motomi Ito
Optometry (St. Louis, Mo.)|August 7, 2001
A comparison of the visual symptoms between ADD/ADHD and normal childrenR Farrar, M Call, W C Maples
American Journal of Botany|April 9, 2016
Cryptic speciation in allotetraploids: Lessons from the Botrychium matricariifolium complexEvelyn W Williams, Donald R Farrar, Don Henson
Allergy and Asthma Proceedings|April 22, 2010
Comprehensive review of olopatadine: the molecule and its clinical entitiesMichael A Kaliner, John Oppenheimer, Judith R Farrar
Allergy and Asthma Proceedings|April 25, 2012
Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data reviewWilliam Storms, Matthew S Bowdish, Judith R Farrar
Clinical Therapeutics|September 1, 1996
A retrospective assessment of cost avoidance associated with the use of nedocromil sodium metered-dose inhaler in the treatment of patients with asthmaP Thomas, R N Ross, J R Farrar
Pageof 10